In this issue, guest editors bring their considerable expertise to this important topic.
- Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field
- Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews
Inhaltsverzeichnis
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms
18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies
Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
Fibroblast Activation Protein Inhibitor Theranostics
PET-CT Based Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings
>fluorodeoxyglucose PET/Computed Tomography Applications
Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities
Utility of PET/Computed Tomography in Infection and Inflammation Imaging
Role of Fluorodeoxyglucose-PET in Interventional Radiology